Beyond current successes, Eli Lilly is innovating with a potential game-changing oral GLP-1, orforglipron. Read why I ...

In a trial, the daily GLP-1 pill showed "significant" results and similar side effects to injectable GLP-1 drugs like Ozempic ...

Fueled by a sustained boom in sales of its diabetes and obesity products, Eli Lilly will become the world’s top-seller of prescription drugs by 2030 and will hold the top rung by a wide margin. | ...

Eli Lilly said the response for its blockbuster drug Mounjaro has been "positive" in India, adding that it is focusing on ...

On Saturday, the shops and restaurants along Main Street in Zionsville are coming together for a special cause – a fundraiser for the Alzheimer’s Association. Mark Wallis, Director of Community ...

Key Points. Visa, Netflix and Eli Lilly are moving closer to the trillion dollar club. While all three have the potential, one will reach $3 trillion sooner than the others.

Rafael Angel Rivera-Ortiz, 40, of South 10th Street in Lebanon, was charged on Friday, June 6, with drug delivery resulting in death, according to the Berks County District Attorney’s Office On March ...

Eli Lilly (LLY) is one of the stocks most watched by Zacks.com visitors lately. So, it might be a good idea to review some of the factors that might affect the near-term performance of the stock.

Eli Lilly and Company (LLY)’s share was trading at $765.68 as of 5 th June. LLY’s trailing and forward P/E were 62.30 and 35.09 respectively according to Yahoo Finance.

The Japanese biotech behind Eli Lilly’s new blockbuster obesity pill believes it could be used with an anti-muscle wasting drug it has developed to create a new standard of patient care for ...

Eli Lilly (NYSE: LLY) sells a broad range of medicines, from cancer and immunology drugs to treatments for migraine. Right now, Lilly sells tirzepatide, commercialized as Mounjaro for type 2 ...